2022
DOI: 10.17344/acsi.2022.7516
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Crystal Structure and Biological Activity of Two Triketone-Containing Quinoxalines as HPPD Inhibitors

Abstract: Two new triketone-containing quinoxaline derivatives were designed by fragment splicing strategy and synthesized using 3,4-diaminobenzoic acid and substituted cyclohexanedione as starting materials. Both compounds were characterized by IR, 1H and 13C NMR, HRMS and X-ray diffraction. 3-Hydroxy-5-methyl-2-(quinoxaline-6-carbonyl)cyclohex-2-en-1-one (6a) crystallized in the triclinic system, space group Pī, a = 7.9829(2) Å, b = 8.1462(2) Å, c = 10.7057(3) Å, α = 84.3590(10)°, β = 89.7760(10)°, γ = 87.4190(10)°, Z… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 34 publications
0
0
0
Order By: Relevance